The incidence and determinants of primary nonadherence with prescribed medication in primary care: A cohort study

Annals of Internal Medicine

Volumn 160, Issue 7, 2014, Pages 441-450

  Tamblyn, Robyn ^a,b   Eguale, Tewodros ^a,b   Huang, Allen ^a,b   Winslade, Nancy ^a,b   Doran, Pamela ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; ANALGESIC AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFLAMMATORY AGENT; ANTILIPEMIC AGENT; ANTIPYRETIC AGENT; ANTITHYROID AGENT; ANTIULCER AGENT; ANTIVIRUS AGENT; DIURETIC AGENT;

ADULT; AGED; ARTICLE; CANADA; COHORT ANALYSIS; DRUG COST; ELECTRONIC MEDICAL RECORD; FEMALE; HUMAN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIMARY NONADHERENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT REFUSAL; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CANADA; COMORBIDITY; FEMALE; HOSPITALIZATION; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; OFFICE VISITS; PRESCRIPTION FEES; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84897460376     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M13-1705     Document Type: Article

References (71)

1. Halpin HA, Morales-Suárez-Varela MM, Martin-Moreno JM. Chronic disease prevention and the new public health. Public Health Rev. 2010;32: 120-54.
2. Daar AS, Singer PA, Persad DL, Pramming SK, Matthews DR, Beaglehole R, et al. Grand challenges in chronic non-communicable diseases. Nature. 2007; 450:494-6. [PMID: 18033288].
3. van der Linden CM, Jansen PA, van Geerenstein EV, van Marum RJ, Grouls RJ, Egberts TC, et al. Reasons for discontinuation of medication during hospitalization and documentation thereof: a descriptive study of 400 geriatric and internal medicine patients [Letter]. Arch Intern Med. 2010;170:1085-7. [PMID: 20585080].
4. Tunstall-Pedoe H. Preventing Chronic Diseases. A Vital Investment. WHO Global Report. Geneva: World Health Organization; 2005. Accessed at www .who.int/chp/chronic-disease-report/en on 31 January 2014.
5. Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation. 2009;119:3028-35. [PMID: 19528344].
6. Yang Y, Thumula V, Pace PF, Banahan III BF, Wilkin NE, Lobb WB. Medication nonadherence and the risks of hospitalization, emergency department visits, and death among Medicare Part D enrollees with diabetes. Drug Benefit Trends. 2009;21:330-8.
7. Halm EA, Mora P, Leventhal H. No symptoms, no asthma: the acute episodic disease belief is associated with poor self-management among inner-city adults with persistent asthma. Chest. 2006;129:573-80. [PMID: 16537854].
8. Solomon MD, Majumdar SR. Primary non-adherence of medications: lifting the veil on prescription-filling behaviors [Editorial]. J Gen Intern Med. 2010;25: 280-1. [PMID: 20195783].
9. Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA. 2002;288:462-7. [PMID: 12132976].
10. Storm A, Andersen SE, Benfeldt E, Serup J. One in 3 prescriptions are never redeemed: primary nonadherence in an outpatient clinic. J Am Acad Dermatol. 2008;59:27-33. [PMID: 18467003].
11. Shah NR, Hirsch AG, Zacker C, Wood GC, Schoenthaler A, Ogedegbe G, et al. Predictors of first-fill adherence for patients with hypertension. Am J Hypertens. 2009;22:392-6. [PMID: 19180061].
12. Ko DT, Chiu M, Guo H, Austin PC, Marquis JF, Tu JV. Patterns of use of thienopyridine therapy after percutaneous coronary interventions with drugeluting stents and bare-metal stents. Am Heart J. 2009;158:592-598.e1. [PMID: 19781419].
13. Fischer MA, Stedman MR, Lii J, Vogeli C, Shrank WH, Brookhart MA, et al. Primary medication non-adherence: analysis of 195,930 electronic prescriptions. J Gen Intern Med. 2010;25:284-90. [PMID: 20131023].
14. Fischer MA, Choudhry NK, Brill G, Avorn J, Schneeweiss S, Hutchins D, et al. Trouble getting started: predictors of primary medication nonadherence. Am J Med. 2011;124:1081.e9-22. [PMID: 22017787].
15. Raebel MA, Ellis JL, Carroll NM, Bayliss EA, McGinnis B, Schroeder EB, et al. Characteristics of patients with primary non-adherence to medications for hypertension, diabetes, and lipid disorders. J Gen Intern Med. 2012;27:57-64. [PMID: 21879374].
16. Shin J, McCombs JS, Sanchez RJ, Udall M, Deminski MC, Cheetham TC. Primary nonadherence to medications in an integrated healthcare setting. Am J Manag Care. 2012;18:426-34. [PMID: 22928758].
17. Cheetham TC, Niu F, Green K, Scott RD, Derose SF, Vansomphone SS, et al. Primary nonadherence to statin medications in a managed care organization. J Manag Care Pharm. 2013;19:367-73. [PMID: 23697474].
18. Reynolds K, Muntner P, Cheetham TC, Harrison TN, Morisky DE, Silverman S, et al. Primary non-adherence to bisphosphonates in an integrated healthcare setting. Osteoporos Int. 2013;24:2509-17. [PMID: 23595561].
19. Derose SF, Green K, Marrett E, Tunceli K, Cheetham TC, Chiu VY, et al. Automated outreach to increase primary adherence to cholesterol-lowering medications. JAMA Intern Med. 2013;173:38-43. [PMID: 23403978].
20. Tamblyn R, Lavoie G, Petrella L, Monette J. The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in Que'bec. J Clin Epidemiol. 1995;48: 999-1009. [PMID: 7775999].
21. Wilchesky M, Tamblyn RM, Huang A. Validation of diagnostic codes in medical services claims data. Can J Clin Pharmacol. 2001;8:39.
22. Tamblyn R, Huang A, Perreault R, Jacques A, Roy D, Hanley J, et al. The medical office of the 21st century (MOXXI): effectiveness of computerized decision-making support in reducing inappropriate prescribing in primary care. CMAJ. 2003;169:549-56. [PMID: 12975221].
23. Eguale T, Tamblyn R, Winslade N, Buckeridge D. Detection of adverse drug events and other treatment outcomes using an electronic prescribing system. Drug Saf. 2008;31:1005-16. [PMID: 18840020].
24. Eguale T, Winslade N, Hanley JA, Buckeridge DL, Tamblyn R. Enhancing pharmacosurveillance with systematic collection of treatment indication in electronic prescribing: a validation study in Canada. Drug Saf. 2010;33:559-67. [PMID: 20553057].
25. Tamblyn R, Huang A, Kawasumi Y, Bartlett G, Grad R, Jacques A, et al. The development and evaluation of an integrated electronic prescribing and drug management system for primary care. J Am Med Inform Assoc. 2006;13:148-59. [PMID: 16357357].
26. Tamblyn R, Reidel K, Huang A, Taylor L, Winslade N, Bartlett G, et al. Increasing the detection and response to adherence problems with cardiovascular medication in primary care through computerized drug management systems: a randomized controlled trial. Med Decis Making. 2010;30:176-88. [PMID: 19675319].
27. American Society of Hospital Pharmacists. AHFS Drug Information: 2012. Bethesda, MD: American Society of Health-System Pharmacists; 2012.
28. World Health Organization. International Statistical Classification of Diseases and Related Health Problems 10th Revision. 2010. Accessed at http://apps.who.int/classifications/icd10/browse/2010/en on 31 January 2014.
29. Hakim A. E-prescribing and primary noncompliance: physician and patient experience. Prof Case Manag. 2010;15:62-7. [PMID: 20234287].
30. Jackevicius CA, Li P, Tu JV. Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction. Circulation. 2008;117: 1028-36. [PMID: 18299512].
31. Briesacher B, Ross-Degnan D, Adams A, Wagner A, Gurwitz J, Soumerai S. A new measure of medication affordability. Soc Work Public Health. 2009; 24:600-12. [PMID: 19821195].
32. Lexchin J, Grootendorst P. Effects of prescription drug user fees on drug and health services use and on health status in vulnerable populations: a systematic review of the evidence. Int J Health Serv. 2004;34:101-22. [PMID: 15088676].
33. Tamblyn R, Laprise R, Hanley JA, Abrahamowicz M, Scott S, Mayo N, et al. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA. 2001;285:421-9. [PMID: 11242426].
34. Wilkins R. Use of postal codes and addresses in the analysis of health data. Health Rep. 1993;5:157-77. [PMID: 8292756].
35. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-83. [PMID: 3558716].
36. Tamblyn R, Abrahamowicz M, Dauphinee D, Wenghofer E, Jacques A, Klass D, et al. Influence of physicians' management and communication ability on patients' persistence with antihypertensive medication. Arch Intern Med. 2010;170:1064-72. [PMID: 20585073].
37. Ekedahl A, Månsson N. Unclaimed prescriptions after automated prescription transmittals to pharmacies. Pharm World Sci. 2004;26:26-31. [PMID: 15018256].
38. Ananth CV, Kantor ML. Modeling multivariate binary responses with multiple levels of nesting based on alternating logistic regressions: an application to caries aggregation. J Dent Res. 2004;83:776-81. [PMID: 15381718].
39. Carey V, Zeger SL, Diggle P. Modelling multivariate binary data with alternating logistic regressions. Biometrika. 1993;80:517-26.
40. Preisser JS, Arcury TA, Quandt SA. Detecting patterns of occupational illness clustering with alternating logistic regressions applied to longitudinal data. Am J Epidemiol. 2003;158:495-501. [PMID: 12936905].
41. Fang R, Kmetic A, Millar J, Drasic L. Disparities in chronic disease among Canada's low-income populations. Prev Chronic Dis. 2009;6:A115. [PMID: 19754991].
42. Shah NR, Hirsch AG, Zacker C, Taylor S, Wood GC, Stewart WF. Factors associated with first-fill adherence rates for diabetic medications: a cohort study. J Gen Intern Med. 2009;24:233-7. [PMID: 19093157].
43. Kraut A, Walld R, Tate R, Mustard C. Impact of diabetes on employment and income in Manitoba, Canada. Diabetes Care. 2001;24:64-8. [PMID: 11194243].
44. Alter DA, Brandes S, Irvine J, Iron K. Impact of socioeconomic status on cardiovascular outcomes in Canada. Expert Rev Pharmacoecon Outcomes Res. 2003;3:691-702. [PMID: 19807347].
45. Banks J, Marmot M, Oldfield Z, Smith JP. Disease and disadvantage in the United States and in England. JAMA. 2006;295:2037-45. [PMID: 16670412].
46. McWilliams JM, Meara E, Zaslavsky AM, Ayanian JZ. Differences in control of cardiovascular disease and diabetes by race, ethnicity, and education: U.S. trends from 1999 to 2006 and effects of medicare coverage. Ann Intern Med. 2009;150:505-15. [PMID: 19380852].
47. Braveman PA, Cubbin C, Egerter S, Williams DR, Pamuk E. Socioeconomic disparities in health in the United States: what the patterns tell us. Am J Public Health. 2010;100 Suppl 1:S186-96. [PMID: 20147693].
48. Cope SF, Ungar WJ, Glazier RH. Socioeconomic factors and asthma control in children. Pediatr Pulmonol. 2008;43:745-52. [PMID: 18615669].
49. Ungar WJ, Paterson JM, Gomes T, Bikangaga P, Gold M, To T, et al. Relationship of asthma management, socioeconomic status, and medication insurance characteristics to exacerbation frequency in children with asthma. Ann Allergy Asthma Immunol. 2011;106:17-23. [PMID: 21195940].
50. Schuetz B, Mann E, Everett W. Educating health professionals collaboratively for team-based primary care. Health Aff (Millwood). 2010;29:1476-80. [PMID: 20679650].
51. Calman NS, Golub M, Shuman S. Primary care and health reform. Mt Sinai J Med. 2012;79:527-34. [PMID: 22976358].
52. Samuelson M, Tedeschi P, Aarendonk D, de la Cuesta C, Groenewegen P. Improving interprofessional collaboration in primary care: position paper of the European Forum for Primary Care. Qual Prim Care. 2012;20:303-12. [PMID: 23113915].
53. Haggerty JL, Reid RJ, Freeman GK, Starfield BH, Adair CE, McKendry R. Continuity of care: a multidisciplinary review. BMJ. 2003;327:1219-21. [PMID: 14630762].
54. Rosenthal TC. The medical home: growing evidence to support a new approach to primary care. J Am Board Fam Med. 2008;21:427-40. [PMID: 18772297].
55. Zeber JE, Manias E, Williams AF, Hutchins D, Udezi WA, Roberts CS, et al ISPOR Medication Adherence Good Research Practices Working Group. A systematic literature review of psychosocial and behavioral factors associated with initial medication adherence: a report of the ISPOR medication adherence & persistence special interest group. Value Health. 2013;16:891-900. [PMID: 23947984].
56. Galea S, Tracy M. Participation rates in epidemiologic studies. Ann Epidemiol. 2007;17:643-53. [PMID: 17553702].
57. Knudsen AK, Hotopf M, Skogen JC, Overland S, Mykletun A. The health status of nonparticipants in a population-based health study: the Hordaland Health Study. Am J Epidemiol. 2010;172:1306-14. [PMID: 20843863].
58. Newhouse JP; The Insurance Experiment Group. Free for All? Lessons from the RAND Health Insurance Experiment. London, UK: Harvard Univ Pr; 1993: 8-243.
59. Ayanian JZ, Kohler BA, Abe T, Epstein AM. The relation between health insurance coverage and clinical outcomes among women with breast cancer. N Engl J Med. 1993;329:326-31. [PMID: 8321261].
60. Schoen C, Davis K, DesRoches C, Donelan K, Blendon R. Health insurance markets and income inequality: findings from an international health policy survey. Health Policy. 2000;51:67-85. [PMID: 10699676].
61. Lasser KE, Himmelstein DU, Woolhandler S. Access to care, health status, and health disparities in the United States and Canada: results of a cross-national population-based survey. Am J Public Health. 2006;96:1300-7. [PMID: 16735628].
62. Todd J, Armon C, Griggs A, Poole S, Berman S. Increased rates of morbidity, mortality, and charges for hospitalized children with public or no health insurance as compared with children with private insurance in Colorado and the United States. Pediatrics. 2006;118:577-85. [PMID: 16882810].
63. Lexchin J. A National Pharmacare Plan: Combining Efficiency and Equity. Canadian Centre for Policy Alternatives; 2001. Accessed at www. policyalternatives.ca/sites/default/files/uploads/publications/ National-Office-Pubs/pharmacare.pdf on 31 January 2014.
64. Hynd A, Roughead EE, Preen DB, Glover J, Bulsara M, Semmens J. Increased patient co-payments and changes in PBS-subsidised prescription medicines dispensed in Western Australia. Aust N Z J Public Health. 2009;33:246-52. [PMID: 19630844].
65. Daw JR, Morgan SG. Stitching the gaps in the Canadian public drug coverage patchwork?: a review of provincial pharmacare policy changes from 2000 to 2010. Health Policy. 2012;104:19-26. [PMID: 21978939].
66. Boothe K. How the pace of change affects the scope of reform: pharmaceutical insurance in Canada, Australia, and the United kingdom. J Health Polit Policy Law. 2012;37:779-814. [PMID: 22700948].
67. McKee M, Balabanova D, Basu S, Ricciardi W, Stuckler D. Universal health coverage: a quest for all countries but under threat in some. Value Health. 2013;16:S39-45. [PMID: 23317643].
68. Kennedy J, Morgan S. A cross-national study of prescription nonadherence due to cost: data from the Joint Canada-United States Survey of Health. Clin Ther. 2006;28:1217-24. [PMID: 16982299].
69. Goldman DP, Joyce GF, Zheng Y. Prescription drug cost sharing: associations with medication and medical utilization and spending and health. JAMA. 2007;298:61-9. [PMID: 17609491].
70. Kennedy J, Morgan S. Cost-related prescription nonadherence in the United States and Canada: a system-level comparison using the 2007 International Health Policy Survey in Seven Countries. Clin Ther. 2009;31:213-9. [PMID: 19243719].
71. Law MR, Cheng L, Dhalla IA, Heard D, Morgan SG. The effect of cost on adherence to prescription medications in Canada. CMAJ. 2012;184:297-302. [PMID: 22249979].